Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy

Status unconfirmed · Phase 2

Conditions studied: Breast Cancer

In brief

Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is safe and effective in patients with early stage breast cancer resected by lumpectomy.

Key facts

Study ID

NCT01185145

Run by

Rocky Mountain Cancer Centers

People needed

291

Starts

2004-02-01

Expected to finish

2024-08-01

Last updated by the study team

2013-07-11

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be a Tis, T1, N0, M0 AJC Classification
• Have negative surgical margins (> or = 2 mm) after final surgery
• Should have adequate skin spacing between balloon surface and surface the skin (> 7 mm)*
• Patients with infiltrating lobular histologies should have breast MRI scanning as part of the initial staging to verify localized T1, or Tis disease
• Multifocal findings (define as 2 or more breast quadrants) on MRI scanning should be further evaluated by ultrasound and, if necessary biopsy, to exclude multiquadrant disease.

You may not qualify if…

• Be pregnant or breast-feeding
• Have collagen-vascular disease
• Inadequate surgical margins (< 2 mm)
• Patients with malignant/suspicious calcifications

Where it is running

• Rocky Mountain Cancer Centers - Aurora — Aurora, Colorado, United States
• Rocky Mountain Cancer Centers - Boulder — Boulder, Colorado, United States
• Rocky Mountain Cancer Centers - Midtown — Denver, Colorado, United States
• Rocky Mountain Cancer Centers - Littleton — Littleton, Colorado, United States
• Rocky Mountain Cancer Centers - Sky Ridge — Lone Tree, Colorado, United States
• Rocky Mountain Cancer Centers - Thornton — Thornton, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.